Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C Cancers
Rubinson, Douglas A, Tanaka, Noritaka, Fece de la Cruz, Ferran, Kapner, Kevin S, Rosenthal, Michael H, Norden, Bryanna L, Barnes, Haley, Ehnstrom, Sara, Morales-Giron, Alvin A, Brais, Lauren K, Lemke, Christopher T, Aguirre, Andrew J, Corcoran, Ryan B
Published in Cancer discovery (01.05.2024)
Published in Cancer discovery (01.05.2024)
Get full text
Journal Article
Sotorasib Is a Pan- RAS G12C Inhibitor Capable of Driving Clinical Response in NRAS G12C Cancers
Rubinson, Douglas A., Tanaka, Noritaka, Fece de la Cruz, Ferran, Kapner, Kevin S., Rosenthal, Michael H., Norden, Bryanna L., Barnes, Haley, Ehnstrom, Sara, Morales-Giron, Alvin A., Brais, Lauren K., Lemke, Christopher T., Aguirre, Andrew J., Corcoran, Ryan B.
Published in Cancer discovery (01.05.2024)
Published in Cancer discovery (01.05.2024)
Get full text
Journal Article